Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Shutterstock 1678849696

We are excited to see our portfolio company, Enhanc3D Genomics, included as one of the 6 best UK start-ups.

Next week the UK Bioscience Forum returns to London and will be featuring some of the most exciting startups in the sector. Come and listen to the future…. Andreas Ballis, Ph.D., Enedra Therapeutics Alex Gutteridge, Enedra Therapeutics Joshua Blight, baseimmune Matthew Griffiths, ConcR Debora Lucarelli, Enhanc3D Genomics Ltd Carlos Luzzani, MultiplAI Health R. Anthony Williamson, AlphaBiomics Thank you to all our supporters, Confluence Tax, Palantir Technologies, Potter Clarkson, NIHR (National Institute for Health Research), LifeSci Advisors, LLC, Cytiva, Johnson & Johnson, AstraZeneca, Deloitte, LifeArc, Avantor, Gallagher https://lnkd.in/ggstG4S #UKBSF2021 #lifesciences #biotech

We are delighted to launch the UK Bioscience Forum, which returns to being held in person in London this October!

The last 18 months have seen significant changes in the life sciences sector. While the COVID crisis has led to global challenges and immense suffering, it has also borne technological and scientific acceleration and development, a new global and national focus on drug discovery and healthcare as a priority, and new opportunities for companies in the life sciences sector – as outlined in the government’s Life Sciences Vision.

At the Bioscience Forum, we will discuss some of the most impactful changes that have occurred and consider how we can capture the speed of progress and the national focus on the sector, whether that be changes to financial support and incentives, using data technologies to further support scientific progress, political initiatives to boost UK capability, or exciting companies being launched in new areas.

You will hear from some of the industry's most inspiring figures and gain useful insights to help take your organisation forwards in a new era of biotechnology.

In addition to the keynote sessions, there will be a number of workshops and networking opportunities - both in person and online – as we look to maximise the enjoyment of a live event with some of the good bits that our online platform has to offer.